ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,421,310, issued on Sept. 23, was assigned to CENTESSA PHARMACEUTICALS (UK) Ltd. (Altrincham, Great Britain).
"CD47 binding agents" was invented by William James Jonathan Finlay (Glasgow, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are antibody molecules that bind specifically to CD47 and related nucleic acid molecules, vectors and host cells. Also provided herein are medical uses of such antibody molecules."
The patent was filed on March 27, 2019, under Application No. 17/041,100.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HIT...